Style | Citing Format |
---|---|
MLA | Hosseinpour R, et al.. "Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial." Health Technology Assessment in Action, vol. 9, no. 1, 2025, pp. 1-7. |
APA | Hosseinpour R, Hosseini N, Hekmatzadeh SF, Mehrabi S, Mansourkhani HS, Mohammadshahi M (2025). Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial. Health Technology Assessment in Action, 9(1), 1-7. |
Chicago | Hosseinpour R, Hosseini N, Hekmatzadeh SF, Mehrabi S, Mansourkhani HS, Mohammadshahi M. "Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial." Health Technology Assessment in Action 9, no. 1 (2025): 1-7. |
Harvard | Hosseinpour R et al. (2025) 'Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial', Health Technology Assessment in Action, 9(1), pp. 1-7. |
Vancouver | Hosseinpour R, Hosseini N, Hekmatzadeh SF, Mehrabi S, Mansourkhani HS, Mohammadshahi M. Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial. Health Technology Assessment in Action. 2025;9(1):1-7. |
BibTex | @article{ author = {Hosseinpour R and Hosseini N and Hekmatzadeh SF and Mehrabi S and Mansourkhani HS and Mohammadshahi M}, title = {Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial}, journal = {Health Technology Assessment in Action}, volume = {9}, number = {1}, pages = {1-7}, year = {2025} } |
RIS | TY - JOUR AU - Hosseinpour R AU - Hosseini N AU - Hekmatzadeh SF AU - Mehrabi S AU - Mansourkhani HS AU - Mohammadshahi M TI - Clinical Effect of Teucrium Polium Extract Ointment on Post Pilonidal Sinus Excision Wound Healing: A Randomized Controlled Trial JO - Health Technology Assessment in Action VL - 9 IS - 1 SP - 1 EP - 7 PY - 2025 ER - |